Mount Sinai Department of Medicine shared a post on LinkedIn:
“Deepak L. Bhatt previews 3 late-breaking clinical trials at ACC 2025, including a study on a novel reversal agent for Antiplatelet Therapy.
The trial demonstrated rapid and sustained efficacy, restoring normal blood clotting within minutes – a potential breakthrough for patients requiring urgent surgery or experiencing major bleeding.”